2B型多发性内分泌腺瘤病的自然史、治疗与长期随访:一项国际多中心回顾性研究
这项国际多中心回顾性研究纳入345例携带Met918Thr RET种系突变的2B型多发性内分泌腺瘤病患者,旨在明确总体生存率及甲状腺髓样癌特异性生存率与1岁前早期甲状腺切除术的关系。结果显示1岁前手术者长期缓解率高,但髓样癌特异性生存曲线无显著差异;肾上腺保留手术可行且多数可保留正常肾上腺功能。
要点
- 1岁前甲状腺切除术与高治愈概率相关,但髓样癌特异性生存无显著差异。
- 双侧嗜铬细胞瘤在28岁前诊断率达50%,肾上腺保留手术可行。
- 所有有资料患者均至少有一种内分泌外特征,需提高认识以改善早期识别。
核心结论
- 1岁前甲状腺切除术与高概率治愈相关,但多数患儿在该推荐年龄后才被诊断。
- 肾上腺保留手术在2B型多发性内分泌腺瘤病中可行,并提供获得正常肾上腺功能的良好机会。
- 提高医疗提供者对内分泌外体征和自然史的认识对改善预后至关重要。
研究设计与样本
- 国际多中心回顾性研究,纳入48个中心的注册数据,患者为携带Met918Thr RET变异者,无年龄限制。
- 共纳入345例患者,随访数据来自1970年至2016年。
- 主要目标为确定总体生存率及基于是否在1岁前接受早期甲状腺切除术的甲状腺髓样癌特异性生存率。
主要发现
- 345例患者中338例(98%)接受了甲状腺切除术。
- 总队列中71例(21%)死亡,中位年龄25岁(范围<1-59)。
- 20例在1岁前接受甲状腺切除术,其中18例中15例(83%)获得长期缓解(降钙素不可测),2例死于非甲状腺髓样癌原因。
关键数值与推荐
- 1岁前甲状腺切除术与高概率治愈相关(18例中15例长期缓解)。
- 肾上腺保留手术后长期复发率为10%(3/31),正常肾上腺功能获得率为62%(16/31)。
临床怎么用
- 推荐在1岁前进行甲状腺切除术以争取高概率治愈,但需认识到多数患儿在该年龄后才被诊断。
- 对2B型多发性内分泌腺瘤病患者可考虑肾上腺保留手术以保留肾上腺功能。
- 医疗提供者应熟悉内分泌外体征(类马凡体型、黏膜神经瘤、胃肠道体征)以促进早期识别。
局限性
- 回顾性研究设计。
- 基于注册数据,可能存在数据不完整或选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple endocrine neoplasia type 2B is a rare syndrome caused mainly by Met918Thr germline RET mutation, and characterised by medullary thyroid carcinoma, phaeochromocytoma, and extra-endocrine features. Data are scarce on the natural history of multiple endocrine neoplasia type 2B. We aimed to advance understanding of the phenotype and natural history of multiple endocrine neoplasia type 2B, to increase awareness and improve detection. METHODS: This study was a retrospective, multicentre, international study in patients carrying the Met918Thr RET variant with no age restrictions. The study was done with registry data from 48 centres globally. Data from patients followed-up from 1970 to 2016 were retrieved from May 1, 2016, to May 31, 2018. Our primary objectives were to determine overall survival, and medullary thyroid carcinoma-specific survival based on whether the patient had undergone early thyroidectomy before the age of 1 year. We also assessed remission of medullary thyroid carcinoma, incidence and treatment of phaeochromocytoma, and the penetrance of extra-endocrine features. FINDINGS: 345 patients were included, of whom 338 (98%) had a thyroidectomy. 71 patients (21%) of the total cohort died at a median age of 25 years (range <1-59). Thyroidectomy was done before the age of 1 year in 20 patients, which led to long-term remission (ie, undetectable calcitonin level) in 15 (83%) of 18 individuals (2 patients died of causes unrelated to medullary thyroid carcinoma). Medullary thyroid carcinoma-specific survival curves did not show any significant difference between patients who had thyroidectomy before or after 1 year (comparison of survival curves by log-rank test: p=0·2; hazard ratio 0·35; 95% CI 0.07-1.74). However, there was a significant difference in remission status between patients who underwent thyroidectomy before and after the age of 1 year (p<0·0001). There was a significant difference in remission status between patients who underwent thyroidectomy before and after the age of 1 year (p<0·0001). In the other 318 patients who underwent thyroidectomy after 1 year of age, biochemical and structural remission was obtained in 47 (15%) of 318 individuals. Bilateral phaeochromocytoma was diagnosed in 156 (50%) of 313 patients by 28 years of age. Adrenal-sparing surgery was done in 31 patients: three (10%) of 31 patients had long-term recurrence, while normal adrenal function was obtained in 16 (62%) patients. All patients with available data (n=287) had at least one extra-endocrine feature, including 106 (56%) of 190 patients showing marfanoid body habitus, mucosal neuromas, and gastrointestinal signs. INTERPRETATION: Thyroidectomy done at no later than 1 year of age is associated with a high probability of cure. The reality is that the majority of children with the syndrome will be diagnosed after this recommended age. Adrenal-sparing surgery is feasible in multiple endocrine neoplasia type 2B and affords a good chance for normal adrenal function. To improve the prognosis of such patients, it is imperative that every health-care provider be aware of the extra-endocrine signs and the natural history of this rare syndrome. The implications of this research include increasing awareness of the extra-endocrine symptoms and also recommendations for thyroidectomy before the age of 1 year. FUNDING: None.
引用
- Castinetti F, Waguespack SG, Machens A, et al. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol. 2019. PMID: 30660595. doi:10.1016/S2213-8587(18)30336-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。